Nosso grupo organiza mais de 3.000 Séries de conferências Eventos todos os anos nos EUA, Europa e outros países. Ásia com o apoio de mais 1.000 Sociedades e publica mais de 700 Acesso aberto Periódicos que contém mais de 50.000 personalidades eminentes, cientistas de renome como membros do conselho editorial.
Periódicos de acesso aberto ganhando mais leitores e citações
700 periódicos e 15 milhões de leitores Cada periódico está obtendo mais de 25.000 leitores
Ofokansi KC, Attama AA, Uzor PF and Ovri MO
Infectious diseases caused by multi-resistant strains of Staphylococcus aureus are on the increase and fighting them with natural products may be more efficacious. The aim of this study was to investigate the in vitro antibacterial activity of methanol leaf extract and the solvent fractions of Phyllanthus muellerianus (Kuntze) Excell as well as their combinations with ciprofloxacin against various isolates of Staphylococcus aureus. Phytochemical screening was done following established method while the in vitro antimicrobial properties of the extract and fractions of the extract were investigated by the agar diffusion method. Agar diffusion Checkerboard and Overlay Inoculum susceptibility disc methods were further employed to study the interaction of the extract, fraction and ciprofloxacin against eight (8) isolates of S. aureus. Results showed that the extract and the fractions contain glycosides, flavonoids, saponins and alkaloids. N- Hexane and methylene chloride fractions showed no activity against the test microorganisms, while methanol fraction and methanol crude extract produced a concentration dependent antibacterial activity against the organisms. Result of interaction study revealed synergism in some of the combination ratios but the predominant effects were indifference and antagonism. The study has demonstrated that the leaf extract and the polar fraction of the plant, P. muellerianus, possess potent antibacterial effect against various strains of S. aureus. Combination of the extract or the fraction with ciprofloxacin could be beneficial in treating infections caused by S. aureus.